AGMB
AgomAb Therapeutics NV
8.80$
-0.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|
| -0.34 | -0.32 | -0.27 | -0.34 | |
| 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.01 | 0.03 | 0.03 | 0.01 | |
| -0.04 | 0.00 | 0.03 | -0.04 | |
| 0.01 | 0.00 | 0.00 | 0.01 | |
| -0.01 | – | -0.62 | -0.01 | |
| 0.00 | 0.00 | 0.00 | – | |
| 2.26 | 0.00 | 0.00 | 2.26 | |
| 1.90 | -0.32 | -0.89 | 1.90 | |
| -0.35 | -0.32 | -0.27 | -0.35 |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.